« Return to News | Study Conduct

BBK Worldwide launches Google virtual tours as trial enrollment tool

Wednesday, June 26, 2013 02:35 PM

BBK Worldwide, a patient recruitment company, has launched a new online tool that leverages Google virtual tours for patient engagement. The product features 360 degree imaging that provides a virtual tour of locations where clinical research is conducted. This tool offers potential study participants the opportunity to tour the office space in advance, helping set expectations and lessen concerns about participating.

"It allows for potential study participants, family members and loved ones to explore the study location in advance, at their convenience. This is helpful for individuals who may not be familiar with clinical research," said Matthew Stumm, principal, creative & media strategy, BBK Worldwide.

"Virtual tours are a great way to orient patients," commented Patrick McLaughlin, executive director, Anaheim Clinical Trials. "Site staff can spend a lot of time getting patients accustomed to their space—this technology reduces the burden on site staff and frees them up to focus on patient care."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.